Vaxart, Inc. Active Patents
7 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2022-08-02: Application 17816788; Invention FORMULATIONS FOR SMALL INTESTINAL DELIVERY OF RSV AND NOROVIRUS ANTIGENS; Applicant Vaxart, Inc.; Status Patented Case.
- 2018-11-08: Application 16099969; Invention BICYCLIC FUSED PYRAZOLE DERIVATIVES FOR THE TREATMENT OF RSV; Applicant AVIRAGEN THERAPEUTICS, INC.; Status Patented Case.
- 2017-12-07: Application 15580651; Invention FORMULATIONS FOR SMALL INTESTINAL DELIVERY OF RSV AND NOROVIRUS ANTIGENS; Applicant Vaxart, Inc.; Status Patented Case.
- 2016-09-26: Application 15276208; Invention PIPERIDINE DERIVATIVES AS HUMAN PAPILLOMA VIRUS INHIBITORS; Applicant AVIRAGEN THERAPEUTICS, INC.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-02 | 17816788 | FORMULATIONS FOR SMALL INTESTINAL DELIVERY OF RSV AND NOROVIRUS ANTIGENS | Vaxart, Inc. | Patented Case | 2025-01-07 | 12186407 | US20220378944A1 | George Trager Sean Tucker Leesun Kim Ciaran Scallan | United States United States United States United States | SALVOZA, M FRANCO G |
| 2018-11-08 | 16099969 | BICYCLIC FUSED PYRAZOLE DERIVATIVES FOR THE TREATMENT OF RSV | AVIRAGEN THERAPEUTICS, INC. GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | Patented Case | 2021-02-02 | 10906899 | US20190144441A1 | Richard K. PLEMPER Eddy LEE John VERNACHIO Elyse BOURQUE | United States United States United States Canada | KIFLE, BRUCK |
| 2017-12-07 | 15580651 | FORMULATIONS FOR SMALL INTESTINAL DELIVERY OF RSV AND NOROVIRUS ANTIGENS | Vaxart, Inc. | Patented Case | 2022-09-06 | 11433146 | US20180161458A1 | George Trager Sean Tucker Leesun Kim Ciaran Scallan | United States United States United States United States | SALVOZA, M FRANCO G |
| 2016-09-26 | 15276208 | PIPERIDINE DERIVATIVES AS HUMAN PAPILLOMA VIRUS INHIBITORS | AVIRAGEN THERAPEUTICS, INC. | Patented Case | 2018-05-22 | 9974779 | US20170079968A1 | Marta BLUMENFELD Delphine COMPERE Jean-Michel GAUTHIER | France France France | THOMAS, TIMOTHY P |
| 2016-03-03 | 14916373 | ANHYDROUS CRYSTALLINE FREE BASE FORM OF 6-{2-[1-(6-METHYL-3-PYRIDAZINYL)-4-PIPERIDINYL]ETHOXY}-3-ETHOXY-1,2-BENZISOXAZOLE | BIOTA PHARMACEUTICALS, INC. | Patented Case | 2017-10-31 | 9802926 | US20160194310A1 | Edward LEE David MCALLISTER Andrew TRIGWELL Robert Vincent TUOHY III Peter SNYDER JR. Christa Leisa FRASSETTO | United States Australia Australia United States United States United States | RAO, SAVITHA M |
| 2015-06-24 | 14655266 | METHOD FOR THE SYNTHESIS OF A HYDRAZINE THAT CAN BE USED IN THE TREATMENT OF THE PAPILLOMA VIRUS | AVIRAGEN THERAPEUTICS, INC | Patented Case | 2018-03-06 | 9908858 | US20150353517A1 | Marta BLUMENFELD Delphine COMPERE Marco A. Ciufolini | France France Canada | MICHELSON, BEN S |
| 2014-11-06 | 14399354 | PHARMACEUTICAL COMPOSITION OF A PAPILLOMAVIRUS INHIBITOR | AVIRAGEN THERAPEUTICS, INC. | Patented Case | 2017-06-06 | 9670159 | US20150152051A1 | Marta Blumenfeld Delphine Compere Patricia Francon Michel Hutin | France France France France | ROZOF, TIMOTHY R |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |